A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF TACROLIMUS WITH MYCOPHENOLATE MOFETIL IN PATIENTS WITH SYSTEMIC SCLEROSIS - INTERSTITIAL LUNG DISEASE (INSIST TRIAL)

被引：0
|
作者：
Mathew, J. [1 ]
Kopp, C. [1 ]
Sharma, S. K. [1 ]
Dhir, V. [1 ]
Dhooria, S. [2 ]
Sinha, A. [3 ]
Jain, S. [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Internal Med, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Pulm Med, Chandigarh, India
[3] Post Grad Inst Med Educ & Res, Radiodiag, Chandigarh, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Clinical Trials; Systemic sclerosis; Lungs;
D O I：
10.1136/annrheumdis-2023-eular.3107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0240
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [1] A Randomized Controlled Trial to Compare the Efficacy and Safety of Tacrolimus with Mycophenolate Mofetil in Patients with Systemic Sclerosis - Interstitial Lung Disease ( INSIST TRIAL)
    Sharma, Shefali Khanna
    Mathew, Jithin
    Kopp, Chirag
    Dhir, Varun
    Dhooria, Sahajal
    Sinha, Anindita
    Jain, Sanjay
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5172 - 5174
  • [2] A RANDOMISED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF ORAL MYCOPHENOLATE MOFETIL WITH PLACEBO IN PATIENTS WITH SYSTEMIC SCLEROSIS RELATED EARLY INTERSTITIAL LUNG DISEASE
    Naidu, G.
    Sharma, S.
    Dhir, V.
    Dhooria, S.
    Sinha, A.
    Mb, A.
    Jain, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 751 - 752
  • [3] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Athanasios Koutroumpas
    Athanasios Ziogas
    Ioannis Alexiou
    Georgia Barouta
    Lazaros I. Sakkas
    Clinical Rheumatology, 2010, 29 : 1167 - 1168
  • [4] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [5] Importance of mycophenolate mofetil for treatment of interstitial lung disease in systemic sclerosis
    Schneider, Udo
    Siegert, Elise
    Glaser, Sven
    Kruger, Klaus
    Krause, Andreas
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (09): : 868 - 878
  • [6] Randomized controlled trial of abituzumab in systemic sclerosis-associated interstitial lung disease
    Khanna, Dinesh
    Tashkin, Donald
    Wells, Athol
    Goldin, Jonathan
    Lubell, Martin
    Wax, Steven
    Damian, Doris
    Denton, Christopher
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [7] EFFICACY OF PIRFENIDONE IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE - A RANDOMISED CONTROLLED TRIAL
    Acharya, Nupoor
    Mishra, Debasish
    Dhooria, Sahajal
    Dhir, Varun
    Jain, Sanjay
    Sharma, Shefali Khanna
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 200 - 201
  • [8] Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial
    Kamanamool, N.
    Ingsathit, A.
    Rattanasiri, S.
    Ngamjanyaporn, P.
    Kasitanont, N.
    Chawanasuntorapoj, R.
    Pichaiwong, W.
    Anutrakulchai, S.
    Sangthawan, P.
    Ophascharoensuk, V.
    Avihingsanon, Y.
    Sumethkul, V.
    LUPUS, 2018, 27 (04) : 647 - 656
  • [9] Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial
    G. S. R. S. N. K. Naidu
    Shefali Khanna Sharma
    M. B. Adarsh
    Varun Dhir
    Anindita Sinha
    Sahajal Dhooria
    Sanjay Jain
    Rheumatology International, 2020, 40 : 207 - 216
  • [10] Effect of mycophenolate mofetil (MMF) on systemic sclerosis-related interstitial lung disease with mildly impaired lung function: a double-blind, placebo-controlled, randomized trial
    Naidu, G. S. R. S. N. K.
    Sharma, Shefali Khanna
    Adarsh, M. B.
    Dhir, Varun
    Sinha, Anindita
    Dhooria, Sahajal
    Jain, Sanjay
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (02) : 207 - 216
12345